Quantcast

Latest Cancer Research Stories

2014-06-16 08:29:32

The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16, 2014 /PRNewswire/ -- A unique public-private collaboration among the National Cancer Institute (NCI), part of the National Institutes of Health, SWOG Cancer Research, Friends of Cancer Research (Friends), the Foundation for the National Institutes of Health (FNIH), five pharmaceutical companies (Amgen,...

2014-06-13 08:24:14

Research grant recipient will be studying the contribution of the polycomb repressive complex (PRC2) towards gastric cancer progression. FT. LAUDERDALE, Fla., June 13, 2014 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF), a non-profit organization that raises awareness and funds for stomach cancer, launched its first research grant of $50,000 for a Young Fellowship Award. The organization presented Dr. David Allison with the fellowship on April 5, 2014 at the...

2014-06-11 08:30:00

FLEMINGTON, N.J., June 11, 2014 /PRNewswire/ -- According to the American Cancer Society, lung cancer is the second most common cancer among men and women and the leading cause of death in the United States. In 2014, it is estimated that 224,210 people will be diagnosed with lung cancer. Hunterdon Regional Cancer Center was selected as the only cancer facility in New Jersey to offer a clinical study on a new investigational lung cancer drug called Nivolumab, developed by Bristol-Myers...

2014-06-10 08:30:28

POINT ROBERTS, Wash. and NEW YORK, June 10, 2014 /PRNewswire/ -- Investorideas.com, a global news source covering leading sectors including biotech and medical technology issues a Q&A interview with Mr. James A. Joyce ,Chairman and CEO of Aethlon Medical, Inc. (OTCBB: AEMD). Mr. Joyce shares insight into the emerging Immuno-Oncology market and the opportunity it represents. Q: Investorideas.com How did Aethlon Medical become involved in cancer research? A: James A. Joyce,...

2014-06-10 08:30:04

--Study in Nature Genetics Used PGDx Exome Analysis to Identify Previously Unknown Mutation with Potential as New Drug Target for Lethal Childhood Brain Cancer-- BALTIMORE, June 10, 2014 /PRNewswire/ -- Personal Genome Diagnostics Inc. (PGDx), a provider of advanced cancer genome analysis and testing services, reported that its exome analysis services played a central role in several cancer studies recently published in leading scientific journals. PGDx's exome analysis...

2014-06-05 23:01:58

Barbara and Edward Netter awarded prestigious distinction by the American Society of Gene and Cell Therapy. Washington, DC (PRWEB) June 05, 2014 Barbara Netter and her late husband Edward Netter – Greenwich residents and founders of Alliance for Cancer Gene Therapy (ACGT) – were awarded the prestigious Distinguished Service Award by the American Society of Gene and Cell Therapy (ASGCT) on Thursday, May 22, 2014. The award – presented in Washington, DC before an audience of over...

2014-06-05 08:28:30

LONDON, June 5, 2014 /PRNewswire/ -- Elekta (NSE: EKTAb) and Royal Philips (NYSE: PHG, AEX: PHIA) announced today that The Institute of Cancer Research, London, a world-leading cancer research institution, working with its clinical partner The Royal Marsden NHS Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with a mission to develop an integrated magnetic resonance imaging (MRI) guided radiation therapy system. Uniting an advanced digital linac with an...

2014-06-04 20:22:06

The Pancreatic Cancer Action Network, Rising Tide Foundation for Clinical Research, and Gateway for Cancer Research Award More Than $1.2 Million in Grants MANHATTAN BEACH, Calif., June 4, 2014 /PRNewswire/ -- The Pancreatic Cancer Action Network, Rising Tide Foundation for Clinical Cancer Research (RTF-CCR) and Gateway for Cancer Research have joined forces to fight one of the deadliest and hardest-to-treat cancers. The strategic collaboration has provided $1 million to facilitate...

2014-06-03 12:39:35

WASHINGTON, June 3, 2014 /PRNewswire-USNewswire/ -- Physician researchers from Georgetown Lombardi Comprehensive Cancer Center, in Washington, D.C., and John Theurer Cancer Center (JTCC) in Hackensack, New Jersey, announce today the formation of the Regional Immunotherapy Discovery Program. The Regional Immunotherapy Discovery Program will accelerate discovery and implementation of a new immunotherapy approach, which combines the full potential of two potent strategies currently...

2014-06-03 12:27:34

Institute of Cancer Research Around a quarter of smokers who carry a defect in the BRCA2 gene will develop lung cancer at some point in their lifetime, a large-scale, international study reveals. Scientists announce a previously unknown link between lung cancer and a particular BRCA2 defect, occurring in around 2 per cent of the population, in research published in Nature Genetics today (Sunday). The defect in BRCA2 - best known for its role in breast cancer - increases the risk of...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related